Sarcopenia Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment Type, Distribution Channel, and Geography

Description

List of Tables

According to our latest study on "Sarcopenia Treatment Market Forecast to 2030 - Global Analysis - Treatment Type, and Distribution Channel," the sarcopenia treatment market value is expected to reach US$ 5.264 billion by 2030 from US$ 3.397 billion in 2022. The report highlights trends prevailing in the market and factors driving and hindering the growth of the sarcopenia treatment market.

The growing awareness of sarcopenia and its negative impact on health presents a significant scope for advancements in the fields of healthcare and geriatric care. Many advocacy groups and organizations are proactively taking steps to raise the awareness of sarcopenia among the masses. These organizations often work with medical professionals to keep the public updated on the various aspects of pathogenicity, target patients, prevention, and treatments, among other aspects, along with underlining the value of prompt diagnosis and treatment. The Office on Women's Health (OWH) of the US Department of Health and Human Services launched the national campaign "Stronger than Sarcopenia" in 2023 to magnify the awareness of sarcopenia in women. Research by Health and Human Services shows that more than 45% of the elderly population in the US suffers from sarcopenia, and millions of younger individuals are at risk of developing this condition later in their lives. In line with OWH's "Stronger than Sarcopenia" campaign, women are urged to discuss sarcopenia with their healthcare providers, followed by undergoing screen for the illness and taking appropriate therapy if required.

Sarcopenia has been included in the curricula of medical schools and training programs for healthcare professionals such as physicians, nurses, and physical therapists. For example, the OWH worked with Medscape Education to create continuing medical education (CME) credits for healthcare professionals, which will better equip them to detect and treat sarcopenia in their patients. Mainstream media has expanded its coverage of sarcopenia to include articles, news stories, and documentaries. According to a February 2022 PubMed article, the US Department of Health and Human Services is one of the top funding agencies in the US, sponsoring 1,604 studies on sarcopenia. From 2022, July 4 will be observed as World Sarcopenia Day. Thus, the elevating awareness regarding sarcopenia is likely to bring new growth trends into the sarcopenia treatment market in the coming years.

The sarcopenia treatment market, by treatment type, is segmented into vitamin D and calcium supplements, protein supplements, vitamin B12 supplements, and others. The vitamin D and calcium supplements segment held the largest share of the market in 2022. The sarcopenia treatment market for this segment is anticipated to record the highest CAGR of 6.5% from 2022 to 2030. Being a fat-soluble vitamin, vitamin D is crucial for maintaining calcium homeostasis and healthy bone metabolism. The supplementation of vitamin D has been studied as a useful dietary strategy to reduce the risk of sarcopenia. Older adults with suboptimal vitamin D levels are highly susceptible to sarcopenia, often associated with falls, hospitalization, and other adverse effects.

The Public Health Agency of Canada, the US Department of Health and Human Services, and NIH are a few key primary and secondary sources referred to while preparing the report on the sarcopenia treatment market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the sarcopenia treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global sarcopenia treatment market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00010491

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Sarcopenia Treatment Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Sarcopenia Treatment Market - Key Industry Dynamics

5.1 Sarcopenia Treatment Market - Key Industry Dynamics
5.2 Market Drivers
- 5.2.1 Upsurge in Geriatric Population
- 5.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
5.3 Key Market Restraints:
- 5.3.1 Unavailability of Direct Interventions
5.4 Key Market Opportunities:
- 5.4.1 Products in Clinical Trial Phases
5.5 Future Trends:
- 5.5.1 Rising Awareness About Sarcopenia
5.6 Impact of Drivers and Restraints:

6. Sarcopenia Treatment Market - Global Market Analysis

6.1 Sarcopenia Treatment Market Revenue (US$ Million), 2022 - 2030
6.2 Sarcopenia Treatment Market Forecast and Analysis

7. Sarcopenia Treatment Market Analysis - By Treatment Type

7.1 Vitamin D and Calcium Supplement
- 7.1.1 Overview
- 7.1.2 Vitamin D and Calcium Supplement Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Protein Supplement
- 7.2.1 Overview
- 7.2.2 Protein Supplement Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Vitamin B12 Supplement
- 7.3.1 Overview
- 7.3.2 Vitamin B12 Supplement Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

8. Sarcopenia Treatment Market Analysis - By Distribution Channel

8.1 Pharmacies
- 8.1.1 Overview
- 8.1.2 Pharmacies Market, Revenue and Forecast to 2030 (US$ Million)
8.2 Retail Channels
- 8.2.1 Overview
- 8.2.2 Retail Channels Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Online Channels
- 8.3.1 Overview
- 8.3.2 Online Channels Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Sarcopenia Treatment Market - Geographical Analysis

9.1 Overview
9.2 North America
- 9.2.1 North America Sarcopenia Treatment Market Overview
- 9.2.2 North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 9.2.3 North America Sarcopenia Treatment Market Breakdown by Treatment Type
  - 9.2.3.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
- 9.2.4 North America Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.2.4.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
- 9.2.5 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
  - 9.2.5.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
  - 9.2.5.2 United States Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.2.5.2.1 United States Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.2.5.2.2 United States Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.2.5.3 Canada Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.2.5.3.1 Canada Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.2.5.3.2 Canada Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.2.5.4 Mexico Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.2.5.4.1 Mexico Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.2.5.4.2 Mexico Sarcopenia Treatment Market Breakdown by Distribution Channel
9.3 Europe
- 9.3.1 Europe Sarcopenia Treatment Market Overview
- 9.3.2 Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 9.3.3 Europe Sarcopenia Treatment Market Breakdown by Treatment Type
  - 9.3.3.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
- 9.3.4 Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.3.4.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
- 9.3.5 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
  - 9.3.5.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
  - 9.3.5.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.5.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.3.5.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.3.5.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.5.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.3.5.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.3.5.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.5.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.3.5.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.3.5.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.5.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.3.5.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.3.5.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.5.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.3.5.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.3.5.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.5.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.3.5.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
9.4 Asia Pacific
- 9.4.1 Asia Pacific Sarcopenia Treatment Market Overview
- 9.4.2 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 9.4.3 Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type
  - 9.4.3.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
- 9.4.4 Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.4.4.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
- 9.4.5 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
  - 9.4.5.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
  - 9.4.5.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.4.5.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.4.5.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.4.5.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.4.5.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.4.5.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.4.5.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.4.5.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.4.5.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.4.5.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.4.5.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.4.5.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.4.5.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.4.5.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.4.5.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.4.5.7 Rest of APAC Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.4.5.7.1 Rest of APAC Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.4.5.7.2 Rest of APAC Sarcopenia Treatment Market Breakdown by Distribution Channel
9.5 Middle East and Africa
- 9.5.1 Middle East and Africa Sarcopenia Treatment Market Overview
- 9.5.2 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 9.5.3 Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type
  - 9.5.3.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
- 9.5.4 Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.5.4.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
- 9.5.5 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
  - 9.5.5.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
  - 9.5.5.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.5.5.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.5.5.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.5.5.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.5.5.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.5.5.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.5.5.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.5.5.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.5.5.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.5.5.5 Rest of Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.5.5.5.1 Rest of Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.5.5.5.2 Rest of Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
9.6 South and Central America
- 9.6.1 South and Central America Sarcopenia Treatment Market Overview
- 9.6.2 South and Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 9.6.3 South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type
  - 9.6.3.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
- 9.6.4 South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.6.4.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
- 9.6.5 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
  - 9.6.5.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
  - 9.6.5.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.6.5.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.6.5.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.6.5.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.6.5.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.6.5.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel
  - 9.6.5.4 Rest of South and Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.6.5.4.1 Rest of South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type
    - 9.6.5.4.2 Rest of South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel

10. Sarcopenia Treatment Market-Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Sarcopenia Treatment Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Abbott Laboratories
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Bayer AG
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Metagenics LLC
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Nestle Health Science SA
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Novartis AG
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Pfizer Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Sanofi SA
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Amway Corp
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 GSK Plc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Makers Nutrition LLC
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms